Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Aurinia Pharmaceuticals Inc. company logo
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH)

Profile

Company profile for Aurinia Pharmaceuticals Inc. (AUPH)
MetricValue
Full NameAurinia Pharmaceuticals Inc.
TickerNASDAQ: AUPH
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryCanada
IPO
IndexesNot included
Websiteauriniapharma.com
Employees130

Key Metrics

Aurinia Pharmaceuticals Inc. Key Details
MetricDateValue
Price$14.97
Price, 1D Change+0.67%
Market Cap$2B
-
PE Ratio26.68
Beta0.66
Revenue$235M
Revenue, 1Y Change+33.97%
EPS$0.04
EPS, 1Y Change+107.21%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Aurinia Pharmaceuticals Inc. chart

Events

Aurinia Pharmaceuticals Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last Split1:50
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

AUPH Estimates
MetricDateValue
EPS$0.04
EPS Estimate$0.78
EPS Est. Change+1,889.06%
Revenue$235.13M
Revenue Estimate$280.63M
Revenue Est. Change+19.35%
Current Price$14.97
Price Target-$16.50
Price Tgt. Change-+10.22%

🔒 Log In To Unlock Full Data

EPS

AUPH EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$0.52-$0.54-4.75%
$0.03$0.04+51.15%
$0.78N/A+1,889.06%
$0.94N/A+2,279.13%
AUPH EPS reported versus estimate values chart

Revenue

AUPH revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$174.84M$175.51M+0.38%
$235.68M$235.13M-0.23%
$280.63MN/A+19.35%
$326.80MN/A+38.99%
AUPH revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

AUPH Performance
MetricDateValue
Price, 1Y+93.41%
Price, 3Y+64.32%
Market Cap, 1Y+81.00%
Market Cap, 3Y+52.28%
Revenue, 1Y+33.97%
Revenue, 3Y+415.59%
EPS, 1Y+107.21%
EPS, 3Y+102.81%

🔒 Log In To Unlock Full Data

Technical Indicators

AUPH Technical Indicators
MetricDateValue
Current Price$14.97
SMA 200$11.28
SMA 200 vs Price-24.64%
SMA 50$15.55
SMA 50 vs Price+3.84%
Beta0.66
ATR$0.51
14-Day RSI41.27
10-Day Volatility40.01%
1-Year Volatility46.13%

Dividends

AUPH Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

AUPH Income & Profitability
MetricDateValue
Revenue$235.13M
EPS$0.04
Gross Profit$206.89M
Gross Margin87.99%
Operating Profit$14.07M
Operating Margin5.98%
Net Income$5.75M
Net Margin2.45%
EBITDA$33.52M

🔒 Log In To Unlock Full Data

Financial Health

AUPH Financial Health
MetricDateValue
Debt To Equity0.21
Current Ratio4.57
Quick Ratio4.17
-
F-Score8
Altman Z-Score5.73

Valuations

AUPH Valuations
MetricDateValue
PE Ratio26.68
PS Ratio7.43
PB Ratio5.40
EV/EBITDA14.59
Enterprise ValueN/A-

Balance Sheet

AUPH Balance Sheet
MetricDateValue
Book Value$377.48M
Cash & Equivalents$358.48M
Total Assets$550.65M
Current Assets$446.60M
Total Liabilities$173.17M
Current Liabilities$97.76M
Total Debt$79.37M
Short Term Debt$15.07M
Accounts Payable$5.19M

Expenses

AUPH Expenses
MetricDateValue
Total Expenses$229.38M
Operating Expenses$192.81M
Cost Of Goods Sold$28.25M
SG&A$0.00
D&A$19.45M
Interest Expense$0.00
Income Tax$1.70M

Cash Flow

AUPH Cash Flow
MetricDateValue
CFO$44.39M
CFI$39.26M
CFF-$49.09M
Capex$281.00K
Free Cash Flow$44.11M

Recent analyst updates

AUPH Recent analyst updates
MetricDateValue
Leerink Partners→
Jefferies→
RBC Capital→
RBC Capital→
Cantor Fitzgerald→
Cantor Fitzgerald→
HC Wainwright & Co.→
HC Wainwright & Co.→
Cantor Fitzgerald→
HC Wainwright & Co.→

Analyst sentiment

Sentiment over the past month
AUPH analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
AUPH institutional ownership distribution chart

Screeners with AUPH

Data Sources & References

  1. AUPH Official Website www.auriniapharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1600620/000160062025000106/0001600620-25-000106-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1600620/000160062025000011/0001600620-25-000011-index.htm
  4. AUPH Profile on Yahoo Finance finance.yahoo.com/quote/AUPH
  5. AUPH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/auph

FAQ

  • What is the ticker symbol for Aurinia Pharmaceuticals Inc.?

    The ticker symbol for Aurinia Pharmaceuticals Inc. is NASDAQ:AUPH

  • Does Aurinia Pharmaceuticals Inc. pay dividends?

    No, Aurinia Pharmaceuticals Inc. does not pay dividends

  • What sector is Aurinia Pharmaceuticals Inc. in?

    Aurinia Pharmaceuticals Inc. is in the Healthcare sector

  • What industry is Aurinia Pharmaceuticals Inc. in?

    Aurinia Pharmaceuticals Inc. is in the Biotechnology industry

  • What country is Aurinia Pharmaceuticals Inc. based in?

    Aurinia Pharmaceuticals Inc. is headquartered in Canada

  • When did Aurinia Pharmaceuticals Inc. go public?

    Aurinia Pharmaceuticals Inc. initial public offering (IPO) was on September 3, 2014

  • Is Aurinia Pharmaceuticals Inc. in the S&P 500?

    No, Aurinia Pharmaceuticals Inc. is not included in the S&P 500 index

  • Is Aurinia Pharmaceuticals Inc. in the NASDAQ 100?

    No, Aurinia Pharmaceuticals Inc. is not included in the NASDAQ 100 index

  • Is Aurinia Pharmaceuticals Inc. in the Dow Jones?

    No, Aurinia Pharmaceuticals Inc. is not included in the Dow Jones index

  • When was Aurinia Pharmaceuticals Inc. last earnings report?

    Aurinia Pharmaceuticals Inc.'s most recent earnings report was on November 4, 2025

  • When does Aurinia Pharmaceuticals Inc. report earnings?

    The next expected earnings date for Aurinia Pharmaceuticals Inc. is February 26, 2026